Table of Content

1    Markets
1.1    Market Outlook
1.1.1    Product Definition
1.1.2    Inclusion and Exclusion Criteria
1.1.3    Key Findings
1.2    Industry Outlook
1.2.1    Market Overview
1.2.1.1    Timeline of Emerging Technologies for Infectious Disease Diagnostics
1.2.1.2    Advantages and Limitations of Emerging Infectious Disease Diagnostic Technologies
1.2.1.3    Advantages and Limitations of Point-of-Care Emerging Infectious Disease Diagnostics
1.2.1.4    Current Market Landscape of Emerging Infectious Disease Diagnostics
1.2.1.5    Future Potential
1.2.1.5.1    CRISPR
1.2.1.5.2    NGS
1.2.1.5.3    INAAT
1.2.1.5.4    Digital PCR (dPCR)
1.2.2    Patent Analysis
1.2.2.1    By Year
1.2.2.2    By Country/Organization
1.2.3    Pipeline Analysis
1.2.4    Impact of COVID-19 on Infectious Disease Diagnostics
1.2.4.1    Post-COVID-19 Scenario: A Paradigm Shift to Home-Based Testing
1.2.5    Supply Chain Analysis
1.3    Market Dynamics
1.3.1    Impact Analysis
1.3.2    Drivers
1.3.2.1    Economic Burden of Infectious Diseases
1.3.2.2    Government Support to Advance Research and Facilitate Early Diagnosis of Infectious Diseases Through Funding and Collaboration
1.3.2.3    Increasing Demand for Point-of-Care (POC) and Syndromic Testing
1.3.2.4    Technological Advancements in Molecular Diagnostics
1.3.2.4.1    Isothermal Nucleic Acid Amplification Techniques (INAATs)
1.3.2.4.2    Digital PCR
1.3.2.4.3    CRISPR Technologies
1.3.3    Restraints
1.3.3.1    Poor Reimbursement for Molecular Diagnostic Tests for Infectious Diseases
1.3.3.2    Erratic Trend in Infectious Disease Epidemic Outbreaks Globally
1.3.3.3    Lack of an Established Framework for NGS-based Tests for Infectious Diseases
1.3.4    Opportunities
1.3.4.1    Potential of Molecular Diagnostic Tests in Low-Resource Settings
1.3.4.2    Potential of Rapid Point-of-Care Tests in Managing Antimicrobial Resistance
2    Global Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
2.1    Overview
2.2    Laboratory Testing
2.3    Point-of-Care Testing
3    Global Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
3.1    Overview
3.2    Polymerase Chain Reaction (PCR)
3.2.1    Reverse Transcription PCR (RT-PCR)
3.2.2    Digital PCR
3.3    Immunodiagnostics
3.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
3.5    Next-Generation Sequencing (NGS)
3.6    Other Technologies
4    Global Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
4.1    Overview
4.2    Bacterial
4.3    Viral
4.4    Fungal
4.5    Other Infections
5    Global Emerging Infectious Disease Diagnostics Market (by Disease Type), 2022-2033
5.1    Overview
5.2    Respiratory Infections
5.3    Gastrointestinal Infections
5.4    Sexually Transmitted Infections (STIs)
5.5    Other Infections
6    Global Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
6.1    Overview
6.2    Hospitals and Clinics
6.3    Diagnostic Laboratories
6.4    Other End Users
7    Global Emerging Infectious Disease Diagnostics Market (by Region)
7.1    North America Emerging Infectious Disease Diagnostics Market
7.1.1    Regulatory Framework
7.1.2    Market Dynamics
7.1.2.1    Impact Analysis
7.1.3    Market Sizing and Forecast
7.1.3.1    North America Emerging Infectious Disease Diagnostics Market (by Application)
7.1.3.2    North America Emerging Infectious Disease Diagnostics Market (by Technology)
7.1.3.3    North America Emerging Infectious Disease Diagnostics Market (by Type of Infection)
7.1.3.4    North America Emerging Infectious Disease Diagnostics Market (by Disease Type)
7.1.3.5    North America Emerging Infectious Disease Diagnostics Market (by End User)
7.1.3.6    North America Emerging Infectious Disease Diagnostics Market (by Country)
7.1.3.6.1    U.S.
7.1.3.6.1.1    Market Dynamics
7.1.3.6.1.2    Market Size and Forecast
7.1.3.6.1.2.1    U.S. Emerging Infectious Disease Diagnostics Market (by End User)
7.1.3.6.2    Canada
7.1.3.6.2.1    Market Dynamics
7.1.3.6.2.2    Market Size and Forecast
7.1.3.6.2.2.1    Canada Emerging Infectious Disease Diagnostics Market (by End User)
7.2    Europe Emerging Infectious Disease Diagnostics Market
7.2.1    Regulatory Framework
7.2.2    Market Dynamics
7.2.2.1    Impact Analysis
7.2.3    Market Sizing and Forecast
7.2.3.1    Europe Emerging Infectious Disease Diagnostics Market (by Application)
7.2.3.2    Europe Emerging Infectious Disease Diagnostics Market (by Technology)
7.2.3.3    Europe Emerging Infectious Disease Diagnostics Market (by Type of Infection)
7.2.3.4    Europe Emerging Infectious Disease Diagnostics Market (by Disease Type)
7.2.3.5    Europe Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.1    Germany
7.2.3.5.1.1    Market Dynamics
7.2.3.5.1.2    Market Size and Forecast
7.2.3.5.1.2.1    Germany Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.2    U.K.
7.2.3.5.2.1    Market Dynamics
7.2.3.5.2.2    Market Size and Forecast
7.2.3.5.2.2.1    U.K. Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.3    France
7.2.3.5.3.1    Market Dynamics
7.2.3.5.3.2    Market Size and Forecast
7.2.3.5.3.2.1    France Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.4    Italy
7.2.3.5.4.1    Market Dynamics
7.2.3.5.4.2    Market Size and Forecast
7.2.3.5.4.2.1    Italy Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.5    Spain
7.2.3.5.5.1    Market Dynamics
7.2.3.5.5.2    Market Size and Forecast
7.2.3.5.5.2.1    Spain Emerging Infectious Disease Diagnostics Market (by End User)
7.2.3.5.6    Rest-of-Europe
7.2.3.5.6.1    Market Dynamics
7.2.3.5.6.2    Market Size and Forecast
7.2.3.5.6.2.1    Rest-of-Europe Emerging Infectious Disease Diagnostics Market (by End User)
7.3    Asia-Pacific Emerging Infectious Disease Diagnostics Market
7.3.1    Regulatory Framework
7.3.2    Market Dynamics
7.3.2.1    Impact Analysis
7.3.3    Market Size and Forecast
7.3.3.1    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Application)
7.3.3.2    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Technology)
7.3.3.3    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Type of Infection)
7.3.3.4    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Disease Type)
7.3.3.5    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Country)
7.3.3.6.1    Japan
7.3.3.6.1.1    Market Dynamics
7.3.3.6.1.2    Market Size and Forecast
7.3.3.6.1.2.1    Japan Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6.2    China
7.3.3.6.2.1    Market Dynamics
7.3.3.6.2.2    Market Size and Forecast
7.3.3.6.2.2.1    China Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6.3    Australia
7.3.3.6.3.1    Market Dynamics
7.3.3.6.3.2    Market Size and Forecast
7.3.3.6.3.2.1    Australia Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6.4    South Korea
7.3.3.6.4.1    Market Dynamics
7.3.3.6.4.2    Market Size and Forecast
7.3.3.6.4.2.1    South Korea Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6.5    India
7.3.3.6.5.1    Market Dynamics
7.3.3.6.5.2    Market Size and Forecast
7.3.3.6.5.2.1    India Emerging Infectious Disease Diagnostics Market (by End User)
7.3.3.6.6    Rest-of-Asia-Pacific
7.3.3.6.6.1    Market Dynamics
7.3.3.6.6.2    Market Size and Forecast
7.3.3.6.6.2.1    Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User)
7.4    Latin America Emerging Infectious Disease Diagnostics Market
7.4.1    Regulatory Framework
7.4.2    Market Dynamics
7.4.2.1    Impact Analysis
7.4.3    Market Size and Forecast
7.4.3.1    Latin America Emerging Infectious Disease Diagnostics Market (by Application)
7.4.3.2    Latin America Emerging Infectious Disease Diagnostics Market (by Technology)
7.4.3.3    Latin America Emerging Infectious Disease Diagnostics Market (by Type of Infection)
7.4.3.4    Latin America Emerging Infectious Disease Diagnostics Market (by Disease Type)
7.4.3.5    Latin America Emerging Infectious Disease Diagnostics Market (by End User)
7.4.3.6    Latin America Emerging Infectious Disease Diagnostics Market (by Country)
7.4.3.6.1    Brazil
7.4.3.6.1.1    Market Dynamics
7.4.3.6.1.2    Market Size and Forecast
7.4.3.6.1.2.1    Brazil Emerging Infectious Disease Diagnostics Market (by End User)
7.4.3.6.2    Mexico
7.4.3.6.2.1    Market Dynamics
7.4.3.6.2.2    Market Size and Forecast
7.4.3.6.2.2.1    Mexico Emerging Infectious Disease Diagnostics Market (by End User)
7.4.3.6.3    Rest-of-Latin America
7.4.3.6.3.1    Market Dynamics
7.4.3.6.3.2    Market Size and Forecast
7.4.3.6.3.2.1    Rest-of-Latin America Emerging Infectious Disease Diagnostics Market (by End User)
7.5    Middle East and Africa Emerging Infectious Disease Diagnostics Market
7.5.1    Regulatory Framework
7.5.2    Market Dynamics
7.5.2.1    Impact Analysis
7.5.3    Market Size and Forecast
7.5.3.1    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Application)
7.5.3.2    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Technology)
7.5.3.3    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Type of Infection)
7.5.3.4    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Disease Type)
7.5.3.5    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by End User)
7.5.3.6    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Country)
7.5.3.6.1    U.A.E.
7.5.3.6.1.1    Market Dynamics
7.5.3.6.1.2    Market Size and Forecast
7.5.3.6.1.2.1    U.A.E. Emerging Infectious Disease Diagnostics Market (by End User)
7.5.3.6.2    K.S.A.
7.5.3.6.2.1    Market Dynamics
7.5.3.6.2.2    Market Size and Forecast
7.5.3.6.2.2.1    K.S.A. Emerging Infectious Disease Diagnostics Market (by End User)
7.5.3.6.3    Rest-of-Middle East and Africa
7.5.3.6.3.1    Market Dynamics
7.5.3.6.3.2    Market Size and Forecast
7.5.3.6.3.2.1    Rest-of-Middle East and Africa Emerging Infectious Disease Diagnostics Market (by End User)
8    Markets - Competitive Benchmarking & Company Profiles
8.1    Competitive Landscape
8.1.1    Overview
8.1.2    Corporate Strategies
8.1.2.1    Mergers and Acquisitions
8.1.2.2    Synergistic Activities
8.1.2.3    Business Expansions and Funding
8.1.3    Business Strategies
8.1.3.1    Product Launches/Upgradations/Approvals
8.2    Market Share Analysis
8.3    Emerging Infectious Disease Diagnostics Ecosystem Active Players
8.4    Company Profiles
8.4.1    Abbott Laboratories
8.4.1.1    Company Overview
8.4.1.2    Role of Abbott Laboratories in the Global Emerging Infectious Disease Diagnostics Market
8.4.1.3    Financials
8.4.1.4    Recent Developments
8.4.1.5    Analyst Perspective
8.4.2    Becton, Dickinson and Company
8.4.2.1    Company Overview
8.4.2.2    Role of Becton, Dickinson and Company in the Global Emerging Infectious Disease Diagnostics Market
8.4.2.3    Financials
8.4.2.4    Recent Developments
8.4.2.5    Analyst Perspective
8.4.3    bioMérieux S.A.
8.4.3.1    Company Overview
8.4.3.2    Role of bioMérieux S.A. in the Global Emerging Infectious Disease Diagnostics Market
8.4.3.3    Financials
8.4.3.1    Recent Developments
8.4.3.2    Analyst Perspective
8.4.4    Bio-Rad Laboratories, Inc.
8.4.4.1    Company Overview
8.4.4.2    Role of Bio-Rad Laboratories, Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.4.4.3    Financials
8.4.4.4    Recent Developments
8.4.4.5    Analyst Perspective
8.4.5    Co-Diagnostics, Inc.
8.4.5.1    Company Overview
8.4.5.2    Role of Co-Diagnostics, Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.4.5.3    Recent Developments
8.4.5.4    Analyst Perspective
8.4.6    DANAHER CORPORATION
8.4.6.1    Company Overview
8.4.6.2    Role of DANAHER CORPORATION in the Global Emerging Infectious Disease Diagnostics Market
8.4.6.3    Financials
8.4.6.4    Recent Developments
8.4.6.5    Analyst Perspective
8.4.7    DiaSorin S.p.A.
8.4.7.1    Company Overview
8.4.7.2    Role of DiaSorin S.p.A. in the Global Emerging Infectious Disease Diagnostics Market
8.4.7.3    Financials
8.4.7.4    Recent Developments
8.4.7.5    Analyst Perspective
8.4.8    F. Hoffmann-La Roche Ltd
8.4.8.1    Company Overview
8.4.8.2    Role of F. Hoffmann-La Roche Ltd in the Global Emerging Infectious Disease Diagnostics Market
8.4.8.3    Financials
8.4.8.4    Recent Developments
8.4.8.5    Analyst Perspective
8.4.9    Hologic, Inc.
8.4.9.1    Company Overview
8.4.9.2    Role of Hologic, Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.4.9.3    Financials
8.4.9.4    Recent Developments
8.4.9.5    Analyst Perspective
8.4.10    QIAGEN N.V.
8.4.10.1    Company Overview
8.4.10.2    Role of QIAGEN N.V. in the Global Emerging Infectious Disease Diagnostics Market
8.4.10.3    Financials
8.4.10.4    Recent Developments
8.4.10.5    Analyst Perspective
8.4.11    QuidelOrtho Corporation
8.4.11.1    Company Overview
8.4.11.2    Role of QuidelOrtho Corporation in the Global Emerging Infectious Disease Diagnostics Market
8.4.11.3    Financials
8.4.11.4    Recent Developments
8.4.11.5    Analyst Perspective
8.4.12    T2 Biosystems, Inc.
8.4.12.1    Company Overview
8.4.12.2    Role of T2 Biosystems, Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.4.12.3    Recent Developments
8.4.12.4    Analyst Perspective
8.4.13    Tecan Trading AG
8.4.13.1    Company Overview
8.4.13.2    Role of Tecan Trading AG in the Global Emerging Infectious Disease Diagnostics Market
8.4.13.3    Financials
8.4.13.4    Recent Developments
8.4.13.5    Analyst Perspective
8.4.14    Thermo Fisher Scientific Inc.
8.4.14.1    Company Overview
8.4.14.2    Role of Thermo Fisher Scientific Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.4.14.3    Financials
8.4.14.4    Recent Developments
8.4.14.5    Analyst Perspective
8.4.15    Siemens Healthineers AG
8.4.15.1    Company Overview
8.4.15.2    Role of Siemens Healthineers AG in the Global Emerging Infectious Disease Diagnostics Market
8.4.15.3    Financials
8.4.15.4    Recent Developments
8.4.15.5    Analyst Perspective
8.5    Company Snapshots
8.5.1    CrisprBits
8.5.1.1    Company Overview
8.5.1.2    Role of CrisprBits in the Global Emerging Infectious Disease Diagnostics Market
8.5.1.3    Key Developments
8.5.2    Proof Diagnostics Inc.
8.5.2.1    Company Overview
8.5.2.2    Role of Proof Diagnostics Inc. in the Global Emerging Infectious Disease Diagnostics Market
8.5.2.3    Key Developments
8.5.3    Evvy
8.5.3.1    Company Overview
8.5.3.2    Role of Evvy in the Global Emerging Infectious Disease Diagnostics Market
8.5.3.3    Key Developments
8.5.4    Sherlock Biosciences
8.5.4.1    Company Overview
8.5.4.2    Role of Sherlock Biosciences in the Global Emerging Infectious Disease Diagnostics Market
8.5.4.3    Key Developments
8.5.5    BioExcel Diagnostics
8.5.5.1    Company Overview
8.5.5.2    Role of BioExcel Diagnostics in the Global Emerging Infectious Disease Diagnostics Market
8.5.5.3    Key Developments
8.5.6    En Carta Diagnostics
8.5.6.1    Company Overview
8.5.6.2    Role of En Carta Diagnostics in the Global Emerging Infectious Disease Diagnostics Market
List of Figures
Figure 1:    History of Infectious Disease Outbreaks Globally
Figure 2:    Number of Infectious Disease Outbreaks per Year Reported by the WHO, Global Estimates
Figure 3:    Global Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 4:    Global Emerging Infectious Disease Diagnostics Market, Impact Analysis
Figure 5:    Global Emerging Infectious Disease Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 6:    Global Emerging Infectious Disease Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 7:    Share of Key Developments, January 2019-June 2023
Figure 8:    Global Emerging Infectious Disease Diagnostics Market (by Region), $Billion, 2022 and 2033
Figure 9:    Market Share Analysis for Global Emerging Infectious Disease Diagnostics Market (by Company), 2022
Figure 10:    Key Insights Validated from Primary Interviews
Figure 11:    Global Emerging Infectious Disease Diagnostics Market Segmentation
Figure 12:    Global Emerging Infectious Disease Diagnostics Market Research Methodology
Figure 13:    Primary Research Methodology
Figure 14:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 15:    Top-Down Approach (Segment-Wise Analysis)
Figure 16:    Timeline of Emerging Technologies for Infectious Disease Diagnostics
Figure 17:    Advantages of Emerging Infectious Disease Diagnostic Technologies
Figure 18:    Limitations of Emerging Infectious Disease Diagnostic Technologies
Figure 19:    Key Settings of POC Testing Deployment
Figure 20:    Key Challenges Associated with Point-of-Care Testing
Figure 21:    Global Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 22:    Future Potential of NGS in Infectious Disease Diagnostics
Figure 23:    Number of Molecular Diagnostics Patents for Infectious Diseases (by Year)
Figure 24:    Number of Molecular Diagnostic Patents for Infectious Diseases (by Country/Organization)
Figure 25:    Key Benefits of Home-Based Testing
Figure 26:    Typical Supply Chain for a Diagnostic Test
Figure 27:    Global Emerging Infectious Disease Diagnostics Market, Impact Analysis
Figure 28:    Fiscal Response to the COVID-19 Pandemic (% of GDP)
Figure 29:    Advantages of Point-of-Care Tests in Molecular Diagnostics
Figure 30:    Key Clinical Areas Demanding Commercial Availability of Syndromic Tests
Figure 31:    Advantages of INAAT over PCR
Figure 32:    Number of LAMP Publications on Public Databases, 2016-2022
Figure 33:    Number of INAAT Publications on Public Databases, 2016-2022
Figure 34:    Advantages of Digital PCR over Quantitative Real-Time PCR
Figure 35:    Number of “Digital PCR” Publications on Public Databases, 2016-2022
Figure 36:    Notable Outbreaks of Infectious Diseases in Humans (by Region)
Figure 37:    Number of Infectious Disease Outbreaks per Year Reported by the WHO, Global Estimates
Figure 38:    Global Emerging Infectious Disease Diagnostics Market (by Application)
Figure 39:    Global Emerging Infectious Disease Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 40:    Global Emerging Infectious Disease Diagnostics Market (Laboratory Testing), $Billion, 2022-2033
Figure 41:    Global Emerging Infectious Disease Diagnostics Market (Point-of-Care Testing), $Billion, 2022-2033
Figure 42:    Global Emerging Infectious Disease Diagnostics Market (by Technology)
Figure 43:    Global Emerging Infectious Disease Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 44:    Global Emerging Infectious Disease Diagnostics Market (PCR), $Billion, 2022-2033
Figure 45:    Global Emerging Infectious Disease Diagnostics Market (RT-PCR), $Billion, 2022-2033
Figure 46:    Global Emerging Infectious Disease Diagnostics Market (Digital PCR), $Billion, 2022-2033
Figure 47:    Global Emerging Infectious Disease Diagnostics Market (Immunodiagnostics), $Billion, 2022-2033
Figure 48:    Global Emerging Infectious Disease Diagnostics Market (Isothermal Nucleic Acid Amplification Technology (INAAT)), $Billion, 2022-2033
Figure 49:    Global Emerging Infectious Disease Diagnostics Market (Next-Generation Sequencing (NGS)), $Billion, 2022-2033
Figure 50:    Global Emerging Infectious Disease Diagnostics Market (Other Technologies), $Billion, 2022-2033
Figure 51:    Global Emerging Infectious Disease Diagnostics Market (by Type of Infection)
Figure 52:    Global Emerging Infectious Disease Diagnostics Market (by Type of Infection), Share (%), 2022 and 2033
Figure 53:    Global Emerging Infectious Disease Diagnostics Market (Bacterial), $Billion, 2022-2033
Figure 54:    Global Emerging Infectious Disease Diagnostics Market (Viral), $Billion, 2022-2033
Figure 55:    Global Emerging Infectious Disease Diagnostics Market (Fungal), $Billion, 2022-2033
Figure 56:    Global Emerging Infectious Disease Diagnostics Market (Other Infections), $Billion, 2022-2033
Figure 57:    Global Emerging Infectious Disease Diagnostics Market (by Disease Type)
Figure 58:    Global Emerging Infectious Disease Diagnostics Market (by Disease Type), Share (%), 2022 and 2033
Figure 59:    Global Emerging Infectious Disease Diagnostics Market (Respiratory Infections), $Billion, 2022-2033
Figure 60:    Global Emerging Infectious Disease Diagnostics Market (Gastrointestinal Infections), $Billion, 2022-2033
Figure 61:    Global Emerging Infectious Disease Diagnostics Market (Sexually Transmitted Infections (STIs)), $Billion, 2022-2033
Figure 62:    Global Emerging Infectious Disease Diagnostics Market (Other Infections), $Billion, 2022-2033
Figure 63:    Global Emerging Infectious Disease Diagnostics Market (by End User)
Figure 64:    Global Emerging Infectious Disease Diagnostics Market (by End User), Share (%), 2022 and 2033
Figure 65:    Global Emerging Infectious Disease Diagnostics Market (Hospitals and Clinics), $Billion, 2022-2033
Figure 66:    Global Emerging Infectious Disease Diagnostics Market (Diagnostic Laboratories), $Billion, 2022-2033
Figure 67:    Global Emerging Infectious Disease Diagnostics Market (Other End Users), $Billion, 2022-2033
Figure 68:    North America Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 69:    North America Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 70:    North America Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 71:    North America Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
Figure 72:    North America Emerging Infectious Disease Diagnostics Market (by Disease Type), $Billion, 2022-2033
Figure 73:    North America Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 74:    North America Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 75:    U.S. Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 76:    U.S. Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 77:    Canada Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 78:    Canada Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 79:    Europe Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 80:    Europe Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 81:    Europe Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 82:    Europe Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
Figure 83:    Europe Emerging Infectious Disease Diagnostics Market (by Disease Type), $Billion, 2022-2033
Figure 84:    Europe Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 85:    Europe Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 86:    Germany Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 87:    Germany Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 88:    U.K. Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 89:    U.K. Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 90:    France Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 91:    France Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 92:    Italy Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 93:    Italy Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 94:    Spain Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 95:    Spain Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 96:    Rest-of-Europe Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 97:    Rest-of-Europe Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 98:    Asia-Pacific Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 99:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 100:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 101:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
Figure 102:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Disease Type), $Billion, 2022-2033
Figure 103:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 104:    Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 105:    Japan Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 106:    Japan Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 107:    China Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 108:    China Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 109:    Australia Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 110:    Australia Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 111:    South Korea Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 112:    South Korea Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 113:    India Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 114:    India Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 115:    Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 116:    Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 117:    Latin America Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 118:    Latin America Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 119:    Latin America Emerging Infectious Disease Diagnostics Market (by Technology), $Million, 2022-2033
Figure 120:    Latin America Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Million, 2022-2033
Figure 121:    Latin America Emerging Infectious Disease Diagnostics Market (by Disease Type), $Million, 2022-2033
Figure 122:    Latin America Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 123:    Latin America Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 124:    Brazil Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 125:    Brazil Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 126:    Mexico Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 127:    Mexico Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 128:    Rest-of-Latin America Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 129:    Rest-of-Latin America Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 130:    Middle East and Africa Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 131:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 132:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 133:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
Figure 134:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Disease Type), $Billion, 2022-2033
Figure 135:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 136:    Middle East and Africa Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 137:    U.A.E. Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 138:    U.A.E. Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 139:    K.S.A. Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 140:    K.S.A. Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 141:    Rest-of-Middle East and Africa Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 142:    Rest-of-Middle East and Africa Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 143:    Share of Key Developments, January 2019-June 2023
Figure 144:    Number of Mergers and Acquisitions (by Company), January 2019-June 2023
Figure 145:    Share of Synergistic Activities (by Company), January 2019-June 2023
Figure 146:    Number of Business Expansions and Funding Activities (by Company), January 2019-June 2023
Figure 147:    Number of Product Launches/Upgradations/Approvals (by Company), January 2019-June 2023
Figure 148:    Market Share Analysis for Global Emerging Infectious Disease Diagnostics Market (by Company), 2022
Figure 149:    Global Emerging Infectious Disease Diagnostics Market, Total Number of Companies Profiled
Figure 150:    Abbott Laboratories: Product Portfolio
Figure 151:    Abbott Laboratories: Overall Financials, $Million, 2020-2022
Figure 152:    Abbott Laboratories: Revenue (by Segment), $Million, 2020-2022
Figure 153:    Abbott Laboratories: Revenue (by Region), $Million, 2020-2022
Figure 154:    Abbott Laboratories: R&D Expenditure, $Million, 2020-2022
Figure 155:    Becton, Dickinson and Company (BD): Product Portfolio
Figure 156:    Becton, Dickinson and Company: Overall Financials, $Million, 2020-2022
Figure 157:    Becton, Dickinson and Company: Revenue (by Segment), $Million, 2020-2022
Figure 158:    Becton, Dickinson and Company: Revenue (by Region), $Million, 2020-2022
Figure 159:    Becton, Dickinson and Company: R&D Expenditure, $Million, 2020-2022
Figure 160:    bioMérieux S.A.: Product Portfolio
Figure 161:    bioMérieux S.A.: Overall Financials, $Million, 2020-2022
Figure 162:    bioMérieux S.A.: Revenue (by Segment), $Million, 2020-2022
Figure 163:    bioMérieux S.A.: Revenue (by Region), $Million, 2020-2022
Figure 164:    bioMérieux S.A.: R&D Expenditure, $Million, 2020-2022
Figure 165:    Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 166:    Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
Figure 167:    Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 168:    Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 169:    Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 170:    Co-Diagnostics, Inc.: Product Portfolio
Figure 171:    DANAHER CORPORATION: Product Portfolio
Figure 172:    DANAHER CORPORATION: Overall Financials, $Million, 2020-2022
Figure 173:    DANAHER CORPORATION: Revenue (by Segment), $Million, 2020-2022
Figure 174:    DANAHER CORPORATION: Revenue (by Region), $Million, 2020-2022
Figure 175:    DANAHER CORPORATION: R&D Expenditure, $Million, 2020-2022
Figure 176:    DiaSorin S.p.A.: Product Portfolio
Figure 177:    DiaSorin S.p.A.: Overall Financials, $Million, 2021-2022
Figure 178:    DiaSorin S.p.A.: Revenue (by Region), $Million, 2021-2022
Figure 179:    DiaSorin S.p.A.: R&D Expenditure, $Million, 2021-2022
Figure 180:    F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 181:    F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
Figure 182:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
Figure 183:    F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
Figure 184:    Hologic, Inc.: Product Portfolio
Figure 185:    Hologic, Inc.: Overall Financials, $Million, 2020-2022
Figure 186:    Hologic, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 187:    Hologic, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 188:    Hologic, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 189:    QIAGEN N.V.: Product Portfolio
Figure 190:    QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 191:    QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 192:    QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 193:    QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Figure 194:    QuidelOrtho Corporation: Product Portfolio
Figure 195:    QuidelOrtho Corporation: Overall Financials, $Million, 2020-2022
Figure 196:    QuidelOrtho Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 197:    QuidelOrtho Corporation: Revenue (by Region), $Million, 2020-2022
Figure 198:    QuidelOrtho Corporation: R&D Expenditure, $Million, 2020-2022
Figure 199:    T2 Biosystems, Inc.: Product Portfolio
Figure 200:    Tecan Trading AG: Product Portfolio
Figure 201:    Tecan Trading AG: Overall Financials, $Million, 2020-2022
Figure 202:    Tecan Trading AG: Revenue (by Segment), $Million, 2020-2022
Figure 203:    Tecan Trading AG: Revenue (by Region), $Million, 2020-2022
Figure 204:    Tecan Trading AG: R&D Expenditure, $Million, 2020-2022
Figure 205:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 206:    Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 207:    Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 208:    Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
Figure 209:    Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
Figure 210:    Siemens Healthineers AG: Product Portfolio
Figure 211:    Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
Figure 212:    Siemens Healthineers AG: Revenue (by Segment), $Million, 2020-2022
Figure 213:    Siemens Healthineers AG: Revenue (by Region), $Million, 2020-2022
Figure 214:    Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022
Figure 215:    CrisprBits: Overall Product Portfolio
Figure 216:    Proof Diagnostics Inc.: Overall Product Portfolio
Figure 217:    Evvy: Overall Product Portfolio
Figure 218:    Sherlock Biosciences: Overall Product Portfolio
Figure 219:    BioExcel Diagnostics: Overall Product Portfolio
Figure 220:    En Carta Diagnostics: Overall Product Portfolio
List of Tables
Table 1:    Some of the Key Developments By Companies Leveraging Emerging Technologies in Infectious Disease Diagnostics
Table 2:    Key Product Offerings by Players in the Global Emerging Infectious Disease Diagnostics Market
Table 3:    Key Questions Answered in the Report
Table 4:    Some of the RT-LAMP Assays Developed during COVID-19
Table 5:    Molecular Diagnostic Products for Infectious Diseases Under Development
Table 6:    At-Home COVID-19 Kits Approved for Commercial Use by ICMR
Table 7:    Disease Burden for Infectious Diseases (DALY), Global, Million, 2019
Table 8:    Key Initiatives by Governments Globally
Table 9:    Examples of International Research Consortiums for Managing Response to Infectious Diseases
Table 10:    List of Infectious Disease Outbreaks (by Region and Year)
Table 11:    North America Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 12:    Europe Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 13:    Asia-Pacific Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 14:    Latin America Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 15:    Middle East and Africa Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 16:    Global Emerging Infectious Disease Diagnostics Market, Key Active Players